A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer
Clinical trial NCT04077463 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04077463
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2027-02-12
- Enrollment
- 701
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.